We are live on
!
Find out more
CIC
Carnegie Investment Counsel Portfolio holdings
AUM
$4.99B
1-Year Est. Return
23.08%
This Fund
S&P 500
This Quarter
Est. Return
+2.71%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$693M
AUM Growth
-$15.7M
(-2.2%)
Cap. Flow
+$4.25M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
17.23%
Holding
327
New
12
Increased
116
Reduced
141
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$3.3M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.57M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.05M |
| 4 |
Edgewell Personal Care
EPC
|
+$1M |
| 5 |
PepsiCo
PEP
|
+$925K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.28M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$1.25M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$1.14M |
| 4 |
NVIDIA
NVDA
|
+$1.14M |
| 5 |
Pembina Pipeline
PBA
|
+$803K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.37% |
| 2 | Industrials | 11.45% |
| 3 | Financials | 9.71% |
| 4 | Technology | 9.17% |
| 5 | Consumer Staples | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Procter & Gamble
PG
$338B
| $7.53M | 1.09% |
85,641
+135
| +0.2% | +$11.7K |
|
27
Church & Dwight Co
CHD
$24.4B
| $7.32M | 1.06% |
151,754
+734
| +0.5% | +$36.2K |
|
28
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
| $7.05M | 1.02% |
25,537
-745
| -3% | -$210K |
|
29
Nike
NKE
$60.9B
| $6.95M | 1% |
136,057
-695
| -0.5% | -$39.2K |
|
30
McKesson
MCK
$103B
| $6.86M | 0.99% |
42,681
-2,620
| -6% | -$488K |
|
|
NVO
31
Novo Nordisk
NVO
$206B
| $6.67M | 0.96% |
331,438
+17,786
| +6% | +$441K |
|
32
Vanguard Morningstar Total Stock Market ETF
VTI
$690B
| $6.54M | 0.94% |
59,937
-4,019
| -6% | -$446K |
|
|
ESRX
33
DELISTED
Express Scripts Holding Company
ESRX
| $6.4M | 0.92% |
92,420
-16,679
| -15% | -$1.25M |
|
34
Boeing
BA
$185B
| $6.34M | 0.91% |
47,333
+2,051
| +5% | +$270K |
|
|
35
GSK
GSK
$103B
| $6.2M | 0.89% |
120,440
+60,194
| +100% | +$3.3M |
|
36
LKQ Corp
LKQ
$6.29B
| $6.17M | 0.89% |
186,925
-2,177
| -1% | -$75.5K |
|
|
ANSS
37
DELISTED
Ansys
ANSS
| $5.93M | 0.85% |
65,133
+257
| +0.4% | +$23.9K |
|
|
SCHW
38
Charles Schwab
SCHW
$187B
| $5.81M | 0.84% |
183,240
+16,166
| +10% | +$474K |
|
|
DD
39
DELISTED
Du Pont De Nemours E I
DD
| $5.8M | 0.84% |
84,522
-772
| -0.9% | -$52.4K |
|
40
TJX Companies
TJX
$173B
| $5.53M | 0.8% |
150,566
+9,608
| +7% | +$376K |
|
41
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
| $5.5M | 0.79% |
43,723
+5,896
| +16% | +$747K |
|
42
Ecolab
ECL
$79.9B
| $5.41M | 0.78% |
46,481
-130
| -0.3% | -$15.7K |
|
|
BSCJ
43
DELISTED
Invesco BulletShares 2019 Corporate Bond ETF
BSCJ
| $5.36M | 0.77% |
250,872
+4,135
| +2% | +$88.5K |
|
44
RPM International
RPM
$15B
| $5.3M | 0.77% |
110,995
-2,758
| -2% | -$146K |
|
45
Oracle
ORCL
$416B
| $5.26M | 0.76% |
137,244
-2,002
| -1% | -$81.6K |
|
46
Neogen
NEOG
$2.5B
| $5.05M | 0.73% |
255,795
-11,085
| -4% | -$237K |
|
47
Ubiquiti
UI
$34.9B
| $5.02M | 0.72% |
101,800
+2,700
| +3% | +$130K |
|
|
BSCH
48
DELISTED
Guggenheim BulletShares 2017 Corporate Bond ETF
BSCH
| $4.98M | 0.72% |
219,635
-23,553
| -10% | -$535K |
|
49
Philip Morris
PM
$291B
| $4.88M | 0.7% |
51,041
+138
| +0.3% | +$13.8K |
|
50
McCormick & Company Non-Voting
MKC
$14.2B
| $4.83M | 0.7% |
102,466
-552
| -0.5% | -$28K |
|
Similar funds
MA
SNT
AM
SGM
PAMP
BCM
NL
O
Carnegie Investment Counsel's Q3 2016 Portfolio in Review
As of Q3 2016, Carnegie Investment Counsel held 327 positions worth $693M, down 2.2% from $709M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Carnegie Investment Counsel's Q3 2016 filing shows 12 new, 116 increased, 141 reduced and 12 closed positions. Its largest new stake was Edgewell Personal Care: 12,416 shares worth $952K. The largest sale was Wells Fargo, an estimated $1.28M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Financials.
- Carnegie Investment Counsel's largest Q3 2016 buy was Edgewell Personal Care: 12,416 shares worth $952K.
- Carnegie Investment Counsel added most to GSK in Q3 2016, an estimated $3.3M increase.
- Carnegie Investment Counsel's biggest Q3 2016 reduction was Wells Fargo, cutting an estimated $1.28M.
- Carnegie Investment Counsel fully exited Pembina Pipeline in Q3 2016, selling an estimated $803K.
- Carnegie Investment Counsel's ten largest holdings make up 17% of its $693M portfolio in Q3 2016.
- Carnegie Investment Counsel opened 12 new positions and closed 12 in Q3 2016.
- Carnegie Investment Counsel's portfolio value fell 2.2% quarter-over-quarter to $693M.
Based on Carnegie Investment Counsel's 13F filing for Q3 2016, filed 14 Nov 2016.